XML 40 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2025
Segment Information [Abstract]  
Schedule of Significant Expense Categories Included within Net Loss Presented on the Company's Consolidated Statements of Operations and Comprehensive Loss

In addition to the significant expense categories included within net loss presented on the Company's condensed consolidated statements of operations and comprehensive loss, see below for disaggregated amounts that comprise total operating expenses (in thousands):

 

   Three Months Ended
March 31,
 
   2025   2024 
Personnel-related costs  $8,431   $5,880 
General and overhead costs   3,611    3,082 
           
Program costs          
Briquilimab platform   1,957    1,438 
CMO   2,138    1,133 
CSU   2,746    2,135 
Asthma   1,393    
 
CIndU   885    425 
SCID   523    404 
MDS/AML   118    575 
Total program costs   9,760    6,110 
Total operating expense   21,802    15,072 
Other income, net   561    1,344 
Net loss  $(21,241)  $(13,728)